InVitro International, Inc. IVRO

IVRO Company Overview

InVitro International, Inc. (OTC Pink: IVRO) is a U.S.-based biotechnology and life sciences company focused on alternative toxicology testing methods and non-animal testing technologies. The company has historically operated within the broader biotechnology, contract research, and product safety testing industries, with an emphasis on in vitro testing applications used by cosmetics, personal care, chemical, and consumer product manufacturers. Public disclosures indicate that the company has positioned itself around the growing regulatory and commercial demand for alternatives to animal testing.

The company’s primary activities have included the commercialization of in vitro testing technologies, laboratory testing services, and related intellectual property. Historically, IVRO has also promoted educational and regulatory awareness regarding validated alternative testing methods. Publicly available filings and OTC market disclosures indicate that the company has operated on a relatively small scale compared with larger contract research organizations, and some operational details have varied across reporting periods. Data regarding current revenue concentration and active commercial scale is limited in recent public disclosures.